Nino Keshelava
Affiliations: | Craniofacial Biology | University of Southern California, Los Angeles, CA, United States |
Area:
Cell Biology, Molecular BiologyGoogle:
"Nino Keshelava"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
May WA, Grigoryan RS, Keshelava N, et al. (2013) Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell lines. Plos One. 8: e80060 |
Kang MH, Smith MA, Morton CL, et al. (2011) National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing. Pediatric Blood & Cancer. 56: 239-49 |
Huang JM, Sheard MA, Ji L, et al. (2010) Combination of vorinostat and flavopiridol is selectively cytotoxic to multidrug-resistant neuroblastoma cell lines with mutant TP53. Molecular Cancer Therapeutics. 9: 3289-301 |
Keshelava N, Houghton PJ, Morton CL, et al. (2009) Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing program. Pediatric Blood & Cancer. 53: 505-8 |
Ara T, Song L, Shimada H, et al. (2009) Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells. Cancer Research. 69: 329-37 |
Feng L, Barnhart JR, Seeger RC, et al. (2008) Cdc6 knockdown inhibits human neuroblastoma cell proliferation. Molecular and Cellular Biochemistry. 311: 189-97 |
Houghton PJ, Morton CL, Kolb EA, et al. (2008) Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program. Pediatric Blood & Cancer. 50: 37-45 |
Grigoryan RS, Yang B, Keshelava N, et al. (2007) Flow cytometry analysis of single-strand DNA damage in neuroblastoma cell lines using the F7-26 monoclonal antibody. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 71: 951-60 |
Keshelava N, Davicioni E, Wan Z, et al. (2007) Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide. Journal of the National Cancer Institute. 99: 1107-19 |
Reynolds CP, Kang MH, Keshelava N, et al. (2007) Assessing combinations of cytotoxic agents using leukemia cell lines. Current Drug Targets. 8: 765-71 |